Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 286

Similar articles for PubMed (Select 18496423)

1.

Granulomatous inflammation in nevi undergoing regression (halo phenomenon): a report of 6 cases.

Denianke KS, Gottlieb GJ.

Am J Dermatopathol. 2008 Jun;30(3):233-5. doi: 10.1097/DAD.0b013e31816a8c6d.

PMID:
18496423
2.

Spitz's nevi with halo reaction: a histopathologic study of 17 cases.

Harvell JD, Meehan SA, LeBoit PE.

J Cutan Pathol. 1997 Nov;24(10):611-9.

PMID:
9449488
3.

Halo congenital nevus undergoing spontaneous regression. Involvement of T-cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies.

Tokura Y, Yamanaka K, Wakita H, Kurokawa S, Horiguchi D, Usui A, Sayama S, Takigawa M.

Arch Dermatol. 1994 Aug;130(8):1036-41.

PMID:
8053701
4.

Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones.

Musette P, Bachelez H, Flageul B, Delarbre C, Kourilsky P, Dubertret L, Gachelin G.

J Immunol. 1999 Feb 1;162(3):1789-94.

5.

Congenital melanocytic nevi with halo phenomenon: report of two cases and a review of the literature.

Langer K, Konrad K.

J Dermatol Surg Oncol. 1990 Apr;16(4):377-80. Review.

PMID:
2182687
6.

Histopathological evaluation of halo phenomenon in Spitz nevus.

Yasaka N, Furue M, Tamaki K.

Am J Dermatopathol. 1995 Oct;17(5):484-6.

PMID:
8599454
7.

Halo phenomenon with regression of acquired melanocytic nevi: a case report.

Rados J, Pastar Z, Lipozencić J, Ilić I, Stulhofer Buzina D.

Acta Dermatovenerol Croat. 2009;17(2):139-43.

PMID:
19595273
8.

Halo nevus or halo phenomenon? A study of 142 cases.

Mooney MA, Barr RJ, Buxton MG.

J Cutan Pathol. 1995 Aug;22(4):342-8.

PMID:
7499574
9.

Sclerosing nevus with pseudomelanomatous features.

Fabrizi G, Pennacchia I, Pagliarello C, Massi G.

J Cutan Pathol. 2008 Nov;35(11):995-1002. doi: 10.1111/j.1600-0560.2007.00941.x. Epub 2008 Jun 4.

PMID:
18537860
10.

Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.

Bergman W, Willemze R, de Graaff-Reitsma C, Ruiter DJ.

J Invest Dermatol. 1985 Jul;85(1):25-9.

PMID:
3159801
11.
12.

The immune response in halo nevi.

Zeff RA, Freitag A, Grin CM, Grant-Kels JM.

J Am Acad Dermatol. 1997 Oct;37(4):620-4. Review.

PMID:
9344203
13.

Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression.

King R, Hayzen BA, Page RN, Googe PB, Zeagler D, Mihm MC Jr.

Mod Pathol. 2009 May;22(5):611-7. doi: 10.1038/modpathol.2009.22. Epub 2009 Mar 6.

14.

Unusual clinical presentation of regression in a congenital melanocytic nevus.

Arpaia N, Cassano N, Filotico R, Laricchia F, Vena GA.

Dermatol Surg. 2005 Apr;31(4):471-3.

PMID:
15871327
15.

Melanocytic nevi of the breast: a histologic case-control study.

Rongioletti F, Urso C, Batolo D, Chimenti S, Fanti PA, Filotico R, Gianotti R, Innocenzi D, Lentini M, Tomasini C, Pippione M, Rebora A.

J Cutan Pathol. 2004 Feb;31(2):137-40.

PMID:
14690457
16.

Spontaneous regression of multiple melanocytic nevi after melanoma: report of 3 cases.

Martín JM, Pinazo I, Monteagudo C, Markovic J, Allende A, Jordá E.

Am J Dermatopathol. 2014 Nov;36(11):e183-8. doi: 10.1097/DAD.0000000000000033.

PMID:
25343215
17.

Survival and histopathologic characteristics of human melanocytic nevi transplanted to athymic (nude) mice.

Meyer LJ, Schmidt LA, Goldgar DE, Piepkorn MW.

Am J Dermatopathol. 1995 Aug;17(4):368-73.

PMID:
8600801
18.

Ultrastructure of halo nevi.

Gauthier Y, Surleve-Bazeille JE, Gauthier O, Texier L.

J Cutan Pathol. 1975;2(2):71-81.

PMID:
1228211
19.

Halo eczema around melanocytic nevi.

Brenan J, Kossard S, Krivanek J.

Int J Dermatol. 1985 May;24(4):226-9.

PMID:
4008152
20.

Mucinous changes in melanocytic nevi and review of the literature.

Perdiki M, Bhawan J.

Am J Dermatopathol. 2008 Jun;30(3):236-40. doi: 10.1097/DAD.0b013e318166f452.

PMID:
18496424
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk